Levofloxacin

• Local Antibiotic Delivery for Community Acquired Pneumonia (LANDCAP 2) Pending
  2024-511420-13-00 Phase II 1 country Gentofte Hospital
• ANTIBIOBONTA - Assessment of the interest of a peri-operative antibiotic strategy applied to patients with asymptomatic bacteriuria undergoi… Pending
  2024-515107-19-00 Phase III 1 country Centre Hospitalier Universitaire De Lille
• Optimizing the antibiotic treatment of uncomplicated acute appendicitis - APPAC II Pending
  2024-518984-36-00 Phase IV 1 country Turku University Hospital
• Acute appendicitis and microbiota – etiology and effects of the antimicrobial treatment - MAPPAC Pending
  2024-519392-26-00 Phase IV 1 country Turku University Hospital
• Antibiotic therapy vs. placebo in the treatment of acute uncomplicated appendicitis: a prospective randomized double-blind placebo-controlle… Pending
  2025-520761-44-00 Phase IV 1 country Turku University Hospital
• PREV-CART - “A multicentric phase III randomized clinical trial open-label, comparing immunoglobulin replacement therapy (IgRT) and antibiot… Pending
  2025-521571-30-00 Phase III 1 country Assistance Publique Hopitaux De Paris
• LIBRETTO: Stimulan™ Local Antibiotic Delivery System Versus 4-Week Systemic Antibiotic Therapy for Diabetic Foot Osteomyelitis – A Prospecti… Pending
  2025-524723-52-00 Phase III 1 country Pirkanmaan hyvinvointialue
• Efficacy and safety of Dalbavancin in the treatment of infective Endocarditis caused by gram-positive cocci Pending
  2026-526149-91-00 Phase III 1 country Friedrich-Schiller-Universitaet Jena
• Efficacy and safety of 7 versus 14 days of antibiotic treatment for bacteremia produced by Pseudomonas aeruginosa: a multicenter, randomized… Recruiting
  2023-508441-41-00 Phase IV 1 country Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevil…
• Rifampin-free regimen versus rifampin-containing regimen in the treatment of staphylococcal prosthetic valve endocarditis: a multicenter ran… Recruiting
  2024-518018-22-00 Phase III 1 country Centre Hospitalier Universitaire De Nantes
• Phase IV, randomized, open label, parallel groups clinical trial for evaluating the early Stop of antibiotic Treatment in high-risk febrile … Recruiting
  2025-524264-38-00 Phase IV 1 country Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca
• Rapid Oral Switch in Infectious Endocarditis, the ROSIE study Recruiting
  2025-524484-20-00 Phase IV 1 country UZ Leuven
• The DALBA-study Introduction of the antibiotic dalbavancin in orthopaedic surgery – an evaluation of: • Health economic costs • Patient-repo… Recruiting
  2025-522088-13-00 Phase IV 1 country Region Midtjylland
• Local Antibiotic Delivery for Community Acquired Pneumonia - Pilot study (LANDCAP1) Recruiting
  2024-511413-37-00 Phase II 1 country Gentofte Hospital
• Efficacy of seven and fourteen days of antibiotic treatment in uncomplicated Staphylococcus aureus bacteremia: A randomized, non-blinded, no… Recruiting
  2024-519186-21-01 Phase IV 1 country Hvidovre Hospital
• Efficacy and safety of different antimicrobial DURATions for the treatment of Infections associated with Osteosynthesis Material implanted a… Recruiting
  2023-508442-18-00 Phase III 1 country Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevil…
• CUSTOMIZED ANTIBIOTIC TREATMENT DURATION AMONG HOSPITALIZED PATIENTS WITH MODERATELY SEVERE COMMUNITY-ACQUIRED PNEUMONIA [CAT-CAP] Recruiting
  2023-504208-27-00 Phase III 1 country Assistance Publique Hopitaux De Paris
• Staphylococcus aureus Network Adaptive Platform trial (SNAP) Recruiting
  2023-503582-35-00 Phase IV 4 countries University Medical Center Utrecht
• The RiCOTTA study: Rifampicin Combination Therapy versus Targeted Antibiotic Monotherapy for Infected Joint Prostheses Caused by Staphylococ… Recruiting
  2022-501620-26-00 Phase IV 1 country Leiden University Medical Center
• Study to treat adult patients with Very High-Risk T-cell Acute Lymphoblastic Leukemia (ALL) with Daratumumab in addition to the National ALL… Ended
  2024-511627-34-00 Phase II 1 country Fondazione Gimema Franco Mandelli Onlus
• Randomized, Embedded, Multifactorial Adaptive Platform trial for Community-Acquired Pneumonia (REMAP-CAP) Ended
  2023-507889-89-00 Phase III 13 countries Universitair Medisch Centrum Utrecht
• COTRIVAP - Efficacy of cotrimoxazole as a de-escalation treatment of Ventilator-Associated Pneumonia in intensive care unit Ended
  2023-505108-52-00 Phase III 1 country Assistance Publique Hopitaux De Paris

Showing 1–22 of 22 trials